Funded Tech Companies

Adcytherix

Wondering who invested in Adcytherix? Angelini Ventures, InnoBio Fund and Bpifrance joined the equity holders in this life sciences company.

Company Overview

Contact Information

Company Background Information

Overview

Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer. The company is led by a seasoned management team and is supported by a network of world-leading experts in the field of ADC development.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/16/2025

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jack Elands

        

Chief Financial Officer

Carsten Dehning

        

VP - Operations

Thierry Menguy

        

VP - R & D

Xavier Preville

        

Company Investors

• Angelini Ventures (Regina Hodits)
• InnoBio Fund (Olivier Martinez)
• Bpifrance (Laurent Higueret)
• Andera Partners (Sofia Ioannidou)
• Kurma Partners (Peter Neubeck)
• aMoon Fund
• Surveyor Capital
• RA Capital Management
• Pureos Bioventures (Ximing Ding)
• Pontifax Venture Capital (Ohad Hammer)
• Dawn Biopharma

Browse more funded tech companies:

AdConsent | Addapptation

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary